Scott Rocklage became part of 5AM Ventures in 2003 as a venture partner and later in 2004, became one of the managing partner. The Ph D. holder has more than 30 years of experience in health management as well as responsibilities strategic leadership. He has served in different positions of influence including as the CEO and chairman of Cubist Pharmaceuticals as well as the president and CEO of Salutar and Catalytica. He also chaired the board of Relypsa and Novira. He is currently serving as chairman in cidara, Kinestral and Rennovia among others. He has been an executive chair of a number of well-respected boards.
Dr. Scott Rocklage received his B.S in chemistry from the University of California. His chemistry Ph. D is from MIT. He had the opportunity of conducting researches with the 2005 Nobel peace prizewinner Richard Schrock. He has been responsible for patenting or co-patenting more than 30US inventions. He also has over 100 peer-reviewed publications to his name. He currently has an office in Boston MA.
Its name, 5AM is derived from the fact that the company is at its initial formation stage hence its significance. He attributes his success in his business and career life to excellent organization skills as well as proper time management and scheduling habit. He has a harbor of prioritizing the most important tasks first, which has been a major aspect of his company’s success and learn more about Scott.
He believes that focus on people is a great way to achieve success and this is one thing he would do even more if he had a chance to start over. Choosing the right team for a company is an important step from the beginning. He also believes in taking measured risks repeatedly and this is the advice he would give other entrepreneurs. He believes that success in managing your own entrepreneurship venture is the best way to do well in life and not to work for a fortune 500 company and more information click here.